- Home
- UPLD vs BDTX Comparison
UPLD vs BDTX Comparison
Compare UPLD & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPLD
- BDTX
- Stock Information
- Founded
- UPLD 2010
- BDTX 2014
- Country
- UPLD United States
- BDTX United States
- Employees
- UPLD N/A
- BDTX N/A
- Industry
- UPLD Computer Software: Prepackaged Software
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UPLD Technology
- BDTX Health Care
- Exchange
- UPLD Nasdaq
- BDTX Nasdaq
- Market Cap
- UPLD 115.3M
- BDTX 96.9M
- IPO Year
- UPLD 2014
- BDTX 2020
- Fundamental
- Price
- UPLD $2.88
- BDTX $1.49
- Analyst Decision
- UPLD Hold
- BDTX Strong Buy
- Analyst Count
- UPLD 3
- BDTX 5
- Target Price
- UPLD $3.75
- BDTX $15.60
- AVG Volume (30 Days)
- UPLD 192.4K
- BDTX 8.3M
- Earning Date
- UPLD 03-12-2025
- BDTX 05-08-2025
- Dividend Yield
- UPLD N/A
- BDTX N/A
- EPS Growth
- UPLD N/A
- BDTX N/A
- EPS
- UPLD N/A
- BDTX N/A
- Revenue
- UPLD $274,794,000.00
- BDTX N/A
- Revenue This Year
- UPLD N/A
- BDTX N/A
- Revenue Next Year
- UPLD N/A
- BDTX N/A
- P/E Ratio
- UPLD N/A
- BDTX N/A
- Revenue Growth
- UPLD N/A
- BDTX N/A
- 52 Week Low
- UPLD $1.79
- BDTX $1.46
- 52 Week High
- UPLD $5.64
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- UPLD 34.86
- BDTX 34.38
- Support Level
- UPLD $3.23
- BDTX $1.55
- Resistance Level
- UPLD $3.48
- BDTX $1.84
- Average True Range (ATR)
- UPLD 0.22
- BDTX 0.21
- MACD
- UPLD -0.00
- BDTX -0.00
- Stochastic Oscillator
- UPLD 6.02
- BDTX 2.27
About UPLD Upland Software Inc.
Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.